Welcome to the Future of Health Sciences Connect Oct. 8, 2020 Calendar, Announcements, college-specific pages are among the new features in this one-stop shop for Health Sciences news and information. Read more Image
Cancer and COVID-19: How the Novel Coronavirus Is Affecting Screening and Treatment Oct. 8, 2020 Julie Bauman is an oncologist and the deputy director of the University of Arizona Cancer Center. As a specialist who works with cancer patients every day, she understands their unique vulnerability to COVID-19. Due to this increased risk, doctors at the UA Cancer Center noticed a decrease in patients coming in for preventive screenings at the height of the pandemic, resulting in an increase in advanced cases arriving at the cancer center as the number of coronavirus cases declines. Tucson Weekly
The Novel Coronavirus May Inadvertently Function as a Pain Reliever, Study Suggests Oct. 8, 2020 The virus that causes COVID-19 acts as a pain reliever, suggests the findings of a new study that could offer “one possible explanation for the unrelenting spread” of the disease, researchers said. Researchers with the University of Arizona Health Sciences said SARS-CoV-2, the virus that causes COVID-19, may inadvertently function as a pain reliever, which “may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease. Fox News
Trump Touts Antibody Treatments for COVID-19, but Evidence Is Incomplete Oct. 8, 2020 President Donald Trump continues to tout an experimental treatment he received for COVID-19 as a cure for the disease despite an absence of evidence to back up that claim. Immunobiologist Deepta Bhattacharya at the University of Arizona College of Medicine - Tucson said there's a theoretical chance the treatment could prevent people from developing their own immunity. The monoclonal antibodies may block the part of the virus that the immune system needs to "see" to develop protective immunity. If that's the case, the immune system wouldn't develop its own longer-lasting antibodies. NPR
U of a Researchers Say COVID-19 Can Give a False Sense of Pain Relief Oct. 8, 2020 The University of Arizona researchers have discovered that COVID-19 can give a false sense of pain relief. Many people with COVID-19 don’t show symptoms right away or are asymptomatic entirely, which sparked the interest of researchers at the U of A. KOLD-TV (CBS) Tucson
Talk 980 (KMBZ): Migraines and Green Light Therapy Oct. 8, 2020 Research from the University of Arizona Health Sciences found that people who suffer from migraines may benefit from something called green light therapy which is exactly what it sounds like. Listeners call in to the live Dana & Parks Show and share their experience living with migraines. KMBZ-AM (Kansas City, MO)
Does Coronavirus BLOCK Pain? Study Suggests It Could Act Like a Painkiller to Mask Illness in the Early Stages as the Virus Spreads Throughout the Body Oct. 8, 2020 The novel coronavirus may be able to block pain and mask the illness in its early stages as it spreads throughout the body, a new study suggests. The team, from the University of Arizona Health Sciences, says the findings may explain why nearly half of all patients with COVID-19 experience no symptoms. Daily Mail (UK)
NIH New Innovator Award to Fund UArizona Health Sciences Research on Opioid Addiction and Relapse in Postpartum Women Oct. 7, 2020 The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy. Read more Image
UArizona Researchers Study Pain Relief Caused by Coronavirus Oct. 7, 2020 New research from the University of Arizona Health Sciences could explain why nearly half of all people who get coronavirus show few or no symptoms. KTAR News, Phoenix
Study Confirms Genetic Link in Cerebral Palsy Oct. 7, 2020 An international research team has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder. Michael Kruer, a neurogeneticist at Phoenix Children’s Hospital and the University of Arizona College of Medicine – Phoenix, is senior author of the study. Health News Digest